- Philogen Provides Corporate Update
- Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications
- Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)
- PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS
Philogen SpA (PHIL:MIL) closed at 14.30, 10.00% above its 52-week low of 13.00, set on Mar 17, 2022.
13.00Mar 17 202215.68Sep 06 2021
Markit short selling activity
|Market cap||415.25m EUR|
|EPS (TTM)||-0.3957 |
Data delayed at least 15 minutes, as of Aug 12 2022 16:35 BST.